The first year to 18 months of an accountable care organization (ACO) is the most challenging as data begins to trickle in of everywhere a patient went to get care, and healthcare providers typically aren't taught how to utilize that information, said Pam Halvorson, regional vice president of clinic operations with Trinity Pioneer ACO.
The first year to 18 months of an accountable care organization (ACO) is the most challenging as data begins to trickle in of everywhere a patient went to get care, and healthcare providers typically aren't taught how to utilize that information, said Pam Halvorson, regional vice president of clinic operations with Trinity Pioneer ACO.
Transcript (slightly modified for readability)
What is the biggest challenge that accountable care organizations have to overcome in order to work as they are supposed to?
I think essentially the biggest problem that all the ACOs are having would be that it would be the first time in the formation of ACOs that you're actually seeing the claims data and you're seeing it across a broad spectrum, everywhere patients went, to every provider they went, anyone who is billing Medicare, for instance, or the commercial insurer. And the skillsets in the healthcare world are not to understand how to drill and manage that level of data coming in.
So your analyst becomes your best friend and you learn terms like "actuarial." Terms that normally for a healthcare provider or direct provider are words that you never would have used. So I see that as taking that first year and 18 months just to learn the nuances of how you read, look, discern, split, and find usable actionable healthcare program design, within all that data that really we've never had before.
How do accountable care organizations handle data, and how does it differ from other health delivery systems?
When you think about what you're receiving in claims, while you have internal data in a regular healthcare environment—whatever you produced, whatever you build, whatever given entity that is oftentimes within billing entities of a health system—even if you belong to the same system those basic business systems may be running separately. So aggregating that and making sense out of it was a challenge prior to things like ACOs and claims data.
Now you're going to add claims data and you're going to see everything outside of your walls. And you're going to see where and how much the names of all the providers who might have provided care to your patient and to really get a good picture of what that patient is doing. There's lots and lots of "ah-ha" moments and surprises when you begin to really understand what it is you're looking at.
Sequencing CAR T and Bispecifics for Multiple Myeloma: Tyler Sandahl, PharmD
July 8th 2025Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, explains that sequencing novel multiple myeloma therapies with CAR T-cell therapy is generally prioritized first for eligible patients, while bispecific antibodies are reserved for later lines or for patients unable to tolerate CAR T.
Read More
Driving Value via Outcomes-Based Pricing and EHR Interoperability: Tyler Sandahl, PharmD
July 7th 2025Tyler Sandahl, PharmD, a clinical pharmacist at Mayo Clinic, discussed the complexities of alternative payment models for chimeric antigen receptor T-cell and bispecific therapies and the need for improved data sharing in cancer care.
Read More
Targeting the Root of gMG With Inebilizumab: A Q&A With Richard Nowak, MD, MS
June 24th 2025In this interview, Richard J. Nowak, MD, MS, principal investigator of the MINT trial of inebilizumab for generalized myasthenia gravis (gMG), discusses the trial’s key findings, including significant improvements in patient- and physician-assessed outcomes, as well as longer-term implications and future areas of investigation.
Read More